Alzheimer’s Disease—A Dysfunction in Cholesterol and Lipid Metabolism

By Lukiw Walter   Pappolla Miguel   Pelaez Ricardo   Bazan Nicolas  

Cellular and Molecular Neurobiology, Vol. 25, Iss. 3-4, 2005-06 ,pp. : 475-483

Springer Publishing Company

Access to resources Recommend Favorite

Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling

By Schliebs Reinhard  

Neurochemical Research, Vol. 30, Iss. 6-7, 2005-06 ,pp. : 895-908

Springer Publishing Company

Access to resources Recommend Favorite

Amyloid-β Decreases Nitric Oxide Production in Cultured Retinal Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer’s Disease?

By Oliveira Leandro   Louzada Paulo   Mello Fernando   Ferreira Sérgio  

Neurochemical Research, Vol. 36, Iss. 1, 2011-01 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease

By Glabe Charles  

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 137-145

Humana Press, Inc

Access to resources Recommend Favorite

Rapid Improvement of Canine Cognitive Dysfunction with Immunotherapy designed for Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-06 ,pp. : 482-493

Bentham Science Publishers

Access to resources Recommend Favorite